Clinical Outcome and Fracture Risk Prediction of Benign Bone Tumors on the Acetabular Dome: 7-Year Clinical Experience and a Finite Element Analysis

Table 2

Patients’ diagnoses and operative data. General and follow-up data of patients.

Case number	Gender/Age	Diagnosis/Enneking grade	Site	Surgical resection Type	Size (cm^3)	Operative type	Blood loss (mL)	Complication
1	M/44	GCT/3	P Column	II, III	8 × 8 × 10	Tumor resection, total hip arthroplasty, and acetabular reconstruction with autologous femoral head	2700	Incision fat liquefaction
2	F/50	GCT with ABC/3	P Column	II, III	5 × 7 × 9	Tumor resection, modular hemipelvic replacement	2500	Incision effusion
3	M/16	FB/1	A + P column	I, II	5.5 × 11.6 × 10.4	Curettage, artificial bone graft	2200	None
4	F/45	FB/1	A + P column	I, II	4.5 × 5 × 5.5	Curettage, iliac bone, artificial bone graft	400	Incision effusion
5	F/14	Hemangioma/2	A column	I, II	3 × 3 × 4	Curettage, allograft, artificial bone graft	400	None
6	M/25	ABC/2	A column	II	2.4 × 3 × 3.8	Curettage, allograft, artificial bone graft	200	None
7	M/22	Langerhans cell histiocytosis/2	A column	I, II	2.2 × 2.7 × 3.7	Curettage, artificial bone graft	250	None
8	M/41	GCT with ABC/3	A + P column, Sacroiliac joint	I, IV	11.9 × 13.1 × 14.5	Tumor resection, stability reconstruction with autologous bone, and internal fixation	3000	Incision effusion
9	M/31	FB/1	A + P column	I, II	8 × 10 × 12.5	Curettage, iliac bone, artificial bone graft	500	None
10	F/51	Diffuse giant cell tumor of tendon sheath/3	A + P column	II, III,V	9 × 12 × 16	Tumor resection, modular hemi-pelvic replacement	2000	Incision fat liquefaction
11	M/49	Hemangioma/2	A + P column	I	4.6 × 5.6 × 7.9	Curettage, bone cement	150	None
12	F/18	Chondroblastoma/2	A + P column	I, II	7 × 8 × 11	Curettage, allograft, artificial bone graft	800	None
13	M/60	FB/1	A column	I	5.5 × 7.2 × 10.3	Curettage, iliac bone, artificial bone graft	400	None
14	F/40	ABC/3	A + P column, Sacroiliac joint	I, IV	10.1 × 13.5 × 17.3	Tumor resection, modular hemipelvic replacement	1000	Incision effusion
15	M/40	Diffuse giant cell tumor of tendon sheath/3	A + P column	I, II, V	17.5 × 20.3 × 22	Tumor resection, total hip arthroplasty, and acetabular reconstruction with autologous femoral head	500	Incision fat liquefaction
16	F/34	Hemangioma/2	Sacroiliac joint	I	2 × 2.5 × 3	Curettage, iliac bone, artificial bone graft	200	None
17	M/44	FB/1	A + P column	I, II	2.6 × 3 × 4.2	Curettage, iliac bone, artificial bone graft	100	Incision fat liquefaction
18	F/42	FB/1	P Column	II	2 × 2 × 2.1	Curettage, iliac bone, artificial bone graft	100	None
19	M/44	SBC/1	A column	II	1.5 × 1.5 × 2	Curettage, iliac bone, artificial bone graft	100	None
20	M/38	GCT with ABC//3	P Column	II, III	5 × 6.3 × 8.2	Tumor resection, total hip arthroplasty and acetabular reconstruction with autologous femoral head	2500/400	Incision effusion
21	M/32	SBC/1	A column	II	2.5 × 4.5 × 2	Curettage, iliac bone, artificial bone graft	200	None
22	M/45	FB/1	A + P column	I, II	6 × 8 × 9.5	Curettage, iliac bone, artificial bone graft	500	None
23	F/42	Hemangioma/3	Sacroiliac joint	I	2 × 2.5 × 3	Curettage, iliac bone, artificial bone graft	200	None
24	M/47	GCT with ABC/3	P Column	II, III	6.0 × 5.5 × 9	Tumor resection, modular hemi-pelvic replacement	2000	Incision fat liquefaction
25	M/54	FB/1	A column	I	5.0 × 7.5 × 8.3	Curettage, iliac bone, artificial bone graft	200	None

A column = anterior column, P column = posterior column, A + P column = anterior + posterior column, GCT = giant cell tumor ABC = aneurysmal bone cyst, SBC = simple bone cyst, FB = fibrous dysplasia.